Page last updated: 2024-10-27

fluoxetine and Lymph Node Metastasis

fluoxetine has been researched along with Lymph Node Metastasis in 1 studies

Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.

Research Excerpts

ExcerptRelevanceReference
"The overexpression of GPM6B in prostate cancer cells could inhibit cell proliferation."1.56GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity. ( Ding, Y; He, S; Huang, Z; Jia, Z; Li, X; Liu, B; Sheng, H, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
He, S1
Huang, Z1
Li, X1
Ding, Y1
Sheng, H1
Liu, B1
Jia, Z1

Other Studies

1 other study available for fluoxetine and Lymph Node Metastasis

ArticleYear
GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity.
    Disease markers, 2020, Volume: 2020

    Topics: Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Fluoxetine; Gene Expressio

2020